Attached files

file filename
10-Q/A - AMENDMENT TO FORM 10-Q - LIBERATOR MEDICAL HOLDINGS, INC.v303300_10qa.htm
EX-31.1 - EXHIBIT 31.1 - LIBERATOR MEDICAL HOLDINGS, INC.v303300_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - LIBERATOR MEDICAL HOLDINGS, INC.v303300_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - LIBERATOR MEDICAL HOLDINGS, INC.v303300_ex31-2.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Mark A. Libratore, the President and Chief Executive Officer of Liberator Medical Holdings, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.          This Quarterly Report on Form 10-Q/A of the Company for the quarter ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

2.          The information contained in this Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: February 21, 2012 /s/ Mark A. Libratore
  Mark A. Libratore,
  President and Chief Executive Officer